Company Encyclopedia
View More
name
CHARMACY PHAR
02289.HK
Charmacy Pharmaceutical Co., Ltd. engages in the pharmaceutical distribution business in the People’s Republic of China. The company distributes western medicines, Chinese patent medicines, healthcare products, and pharmaceutical products to downstream distributors and retail terminals. It also offers pharmaceutical product related consulting services; and operates Charmacy e-Medicine, a B2B e-commerce platform to place orders online, make inquires and payments, etc.
180.82 B
02289.HKMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Health Care DistributorsIndustry
Industry Ranking8/21
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE8.15%B
    • Profit Margin1.14%C
    • Gross Margin7.27%E
  • Growth ScoreD
    • Revenue YoY-5.18%D
    • Net Profit YoY-6.55%C
    • Total Assets YoY8.76%B
    • Net Assets YoY1.81%C
  • Cash ScoreB
    • Cash Flow Margin8789.79%A
    • OCF YoY-5.18%D
  • Operating ScoreA
    • Turnover1.25A
  • Debt ScoreE
    • Gearing Ratio83.05%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    CHARMACY PHAR recommends changing auditors

    CHARMACY PHAR recommends changing auditors, as ShineWing Certified Public Accountants is about to reach the end of its service term. The company has communicated with ShineWing, which has agreed to resign at the conclusion of the upcoming extraordinary general meeting. CHARMACY PHAR proposes to appoint Tianjian Certified Public Accountants as the new auditor after ShineWing's resignation, with a term until the conclusion of the next annual general meeting, subject to shareholder approval

    etnet·
    HK
    02289
    0.00%
    etnet·
    HK
    02289
    0.00%

    CHARMACY PHAR released its interim results, with a net profit attributable to the parent company of 21.739 million yuan, a year-on-year decrease of 18.72%

    According to the Zhitong Finance APP, CHARMACY PHAR released its interim results for the six months ending June 30, 2025, with total operating revenue of 2.155 billion yuan (RMB, the same below), a year-on-year decrease of 8.18%; net profit attributable to the parent company of 21.739 million yuan, a year-on-year decrease of 18.72%; basic earnings per share of 0.2013 yuan

    Zhitong·
    HK
    02289
    0.00%
    Zhitong·
    HK
    02289
    0.00%

    CHARMACY PHAR: Zheng Yuyan has been appointed as a member of the nomination committee

    According to the Zhitong Finance APP, CHARMACY PHAR announced that Mr. Yao Chuanglong, the executive director, will no longer serve as a member of the board nomination committee, and Ms. Zheng Yuyan, the executive director, has been appointed as a member of the nomination committee to replace Mr. Yao Chuanglong, effective from June 27, 2025

    Zhitong·
    HK
    02289
    0.00%
    Zhitong·
    HK
    02289
    0.00%

    CHARMACY PHAR will distribute a final dividend of HKD 0.48895 per share on July 11

    According to the Zhitong Finance APP, CHARMACY PHAR announced that it will distribute a final dividend of HKD 0.48895 per share on July 11, 2025

    Zhitong·
    HK
    02289
    0.00%
    Zhitong·
    HK
    02289
    0.00%

    CHARMACY PHAR released its annual performance report, with a net profit attributable to shareholders of RMB 53.2841 million, an increase of 3.78% year-on-year

    CHARMACY PHAR released its annual performance for the year ended December 31, 2024, with total operating revenue of 4.435 billion yuan, a year-on-year increase of 0.72%; net profit attributable to the parent company of 53.2841 million yuan, a year-on-year increase of 3.78%; basic earnings per share of 0.4934 yuan, and a proposed final dividend of 0.45 yuan per share. The growth in performance is mainly attributed to focusing on the non-tender market and strengthening supply chain advantages, which enhanced customer satisfaction and brand influence

    Zhitong·
    HK
    02289
    0.00%
    Zhitong·
    HK
    02289
    0.00%
    © 2025 Longbridge｜Disclaimer